Amazon is diving deeper into the healthcare business as it launches its new unlimited prescription medication service for just $5 per month. The e-commerce firm has named the service RxPass, and it is exclusively offered to Prime members.
Subscribers of Amazon Pharmacy’s RxPass will be able to enjoy free delivery of medicines even if they order many times. The healthcare subscription service was launched on Tuesday this week and is now available in most states in the U.S.
Moreover, Prime members can also save on medicines since special discounts are also applied on top of the free delivery to homes. This service only shows that the company is slowly but continuously expanding its footprint in the healthcare market.
As per Fox Business, the $5 flat monthly fee covers various medicines, including antibiotic amoxicillin, naproxen anti-inflammatory drug, and sildenafil which is typically used for the treatment of erectile dysfunction. This is commonly known as Viagra and is also said to have the ability to treat some types of high blood pressure.
Even with the low subscription fee for RxPass, customers can fill as many prescriptions as they need. As long as the medicines are on the list, and Amazon said it has 50 generic medications. Some of the generic drugs are said to cost only $1 for a 30-day supply already. For other discounts, they can get up to 80% off on generic and 40% off on brand-name medicines; thus, the subscription is beneficial.
“Prime members already get fast, free delivery on prescription medications, and RxPass is one more way to save with Amazon Pharmacy. Any customer who pays more than $10 a month for their eligible medications will see their prescription costs drop by 50% or more, plus they save time by skipping a trip to the pharmacy,” Amazon Pharmacy’s vice president, John Love, said in a press release. “We are excited to offer our customers surprisingly simple, low pricing on the eligible medications they need each month.”
Photo by: Bastian Riccardi/Pixabay


Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns
Asian Stocks Slip as Oil Rebounds Amid Fed Rate Hike Fears
Bessent Says U.S. Must Strengthen Supply Chains and Economic Security
Asian Stocks Slide as AI Rally Pauses, South Korean Chipmakers Lead Regional Decline
U.S. Dollar Reaches One-Year High as Tech Sell-Off and Fed Rate Hike Expectations Support Demand
Trump Requests $11 Billion More in Farm Aid as Rising Costs Pressure U.S. Farmers
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan
Gold Falls Below $4,000 as Strong Dollar and Fed Rate Hike Expectations Weigh on Prices
Trip.com Shares Tumble After Q1 Profit Drops and Weak Revenue Growth Outlook
White House Seeks $87.6 Billion Emergency Funding for Iran War, Farmers, and Ebola Response
BOJ Hawk Signals Faster Interest Rate Hikes Amid Inflation Risks 



